Community-based unified response to eliminate hepatitis C (CURE) - project title: community-based unified response to eliminate hepatitis C (CURE) applicant organization: meharry medical college…

Active Project Grant Awarded Last action

Award ID
H79TI088392
Recipient
Awarding agency
Obligated
$2,092,500

Award facts

Completion date 55% complete
Funding agency
SAMHSA Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
Place of performance
Nashville, TN 37208, USA

Award details come from USAspending.gov.

About this award

The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded Meharry Medical College a $2.09M Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to implement the Community-Based Unified Response to Eliminate Hepatitis C (CURE) initiative in Nashville/Davidson County, Tennessee. The award, effective September 30, 2025, through September 29, 2027, funds a low-barrier, integrated service delivery model targeting people who use drugs, individuals experiencing homelessness, and those with co-occurring mental illness. The CURE initiative provides same-day hepatitis C virus (HCV) antibody and RNA testing using point-of-care diagnostics, immediate liver staging, and direct-acting antiviral (DAA) therapy initiation across four service sites: the Meharry Addiction Clinic, Elam Mental Health Center, Meharry Community Wellness Center, and HOPE Mobile Outreach Clinic.

Services delivered under this award are co-located and integrated with HIV testing and care, mental health counseling, and medication for opioid and alcohol use disorder (MOUD/MAUD), supported by peer-led recovery services. Over the three-year project period, CURE will provide rapid HCV screening to a minimum of 750 high-risk individuals and initiate DAA treatment for at least 405 participants, with the overarching goal of increasing testing access, treatment retention, and sustained virologic response rates to eliminate HCV among vulnerable populations in the target region.

Description

Community-based unified response to eliminate hepatitis C (CURE) - project title: community-based unified response to eliminate hepatitis C (CURE) applicant organization: meharry medical college target population: people who use drugs (PWUD), individuals experiencing homelessness, and those with CO-occurring mental illness in davidson county, TN strategy: deliver low-barrier, same-day HCV testing and treatment integrated with behavioral health, HIV, and substance use services goal: eliminate HCV among high-risk populations by increasing testing, treatment access, retention, and sustained virologic response (SVR) abstract: the community-based unified response to eliminate hepatitis C (CURE) initiative, led by meharry medical college, seeks to eliminate hepatitis C virus (HCV) among people who use drugs (PWUD), individuals experiencing homelessness, and those living with CO-occurring mental illness in nashville/davidson county, TN. Despite being a national medical education and health equity leader, tennessee has among the highest HCV infection rates in the U.S., exacerbated by fragmented care systems, low medicaid uptake, and limited access to evidence-based treatment for vulnerable populations. The CURE project will implement an integrated, person-centered, and low-barrier model across four service sites: the meharry addiction clinic (MAC), the elam mental health center, the meharry community wellness center (MCWC), and the hope mobile outreach clinic. Services will include same-day HCV antibody and RNA testing using point-of-care diagnostics; immediate liver staging; and initiation of direct-acting antiviral (DAA) therapy. All services are CO-located with HIV testing and care, mental health counseling, medication for opioid and alcohol use disorder (MOUD/MAUD), and peer-led recovery support. Over the 3-YEAR project period, CURE will: provide rapid HCV screening to at least 750 high-risk individuals (250/YEAR); initiate DAA treatment for a minimum of 405 participants; achieve sustained virologic response (SVR12) in ≥85% of those treated; train 10+ prescribers in HCV care using evidence-based curricula; provide CO-located HCV, SUD, and mental health services to 100% of enrolled clients; increase HAV/HBV vaccination rates and implement motivational incentives to support adherence and CURE. The project leverages a unified 340B pharmacy infrastructure, mobile care delivery, and an implementation science evaluation guided by the RE-aim framework. Meharry will coordinate with peer-led housing organizations, tenncare navigators, and harm reduction experts to address structural barriers, improve retention, and advance health equity. The proposed activities are fully aligned with the nofo's required and allowable strategies and will create a replicable model for syndemic care integration in non-medicaid expansion states.

Quick answers

Who received award H79TI088392?

H79TI088392 was awarded to Meharry Medical College by SAMHSA Division of Grants Management (Substance Abuse and Mental Health Services Administration) on September 30, 2025.

How much is award H79TI088392 worth?

$2,092,500 has been obligated on H79TI088392.

Which agency awarded H79TI088392?

SAMHSA Division of Grants Management (Substance Abuse and Mental Health Services Administration) awarded H79TI088392, with funding from SAMHSA Center for Substance Abuse Treatment (Substance Abuse and Mental Health Services Administration).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award